{"disease":{"id":"autosomal-dominant-polycystic-kidney","name":"autosomal dominant polycystic kidney"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT02112136","title":"Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD","phase":"NA","overall_status":"COMPLETED","enrollment_count":1450,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT01214421","title":"Tolvaptan Extension Study in Participants With ADPKD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1083,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03918447","title":"A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":667,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT02925221","title":"Canadian Medical Assessment of JINARC™ Outcomes Registry","phase":"","overall_status":"COMPLETED","enrollment_count":530,"lead_sponsor_name":"Otsuka Canada Pharmaceutical Inc.","has_results":false},{"nct_id":"NCT06747572","title":"Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":401,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT06618638","title":"Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment","phase":"NA","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03749447","title":"An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":270,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT03970018","title":"ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal Pressure?","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"CHU de Reims","has_results":false},{"nct_id":"NCT06759142","title":"Analysis of Patients With Autosomal Dominant Polycystic Kidney","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06345755","title":"A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT02127437","title":"Lanreotide In Polycystic Kidney Disease Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04689074","title":"Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT03273413","title":"Statin Therapy in Patients With Early Stage ADPKD","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT06800651","title":"Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT06582875","title":"Glucagon-Like Peptide-1 Receptor Agonist in ADPKD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04907799","title":"Daily Caloric Restriction in ADPKD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":125,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT07282821","title":"Bempedoic Acid Therapy for Polycystic Kidney Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Kenneth Hallows","has_results":false},{"nct_id":"NCT02729662","title":"Efficacy of Tolvaptan on ADPKD Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":118,"lead_sponsor_name":"Kyorin University","has_results":false},{"nct_id":"NCT03949894","title":"Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Korea Otsuka Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07565441","title":"Drug-Drug Interactions of JMKX003142 in Healthy Participants","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":112,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT03366337","title":"A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT03901521","title":"Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT07217158","title":"Role of ROS and cAMP-PKA Biomarkers in ADPKD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05646420","title":"Thyroid Hormones in ADPKD","phase":"NA","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Mario Negri Institute for Pharmacological Research","has_results":false},{"nct_id":"NCT02964273","title":"Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03203642","title":"Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Kadmon, a Sanofi Company","has_results":true},{"nct_id":"NCT07074327","title":"Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT05500157","title":"Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts","phase":"NA","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04908462","title":"To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"AceLink Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05521191","title":"A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Regulus Therapeutics Inc.","has_results":false},{"nct_id":"NCT04578548","title":"A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":66,"lead_sponsor_name":"Galapagos NV","has_results":true},{"nct_id":"NCT05401409","title":"Effect of Beetroot Juice on Reducing Hypertension in Autosomal Dominant Polycystic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Western Sydney Local Health District","has_results":true},{"nct_id":"NCT07355114","title":"Robotic vs Open Nephrectomy for ADPKD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT06658964","title":"Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT07181265","title":"Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT05228574","title":"Treatment of Vascular Stiffness in ADPKD","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT02933268","title":"High Water Intake in Polycystic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT07228364","title":"Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05190744","title":"Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05478083","title":"A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT07022119","title":"A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT03487913","title":"The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Palladio Biosciences","has_results":true},{"nct_id":"NCT07535385","title":"RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT07161037","title":"Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT03717883","title":"ADPKD Alterations in Hepatic Transporter Function","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT07470177","title":"A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT03541447","title":"Tolvaptan-Octreotide LAR Combination in ADPKD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Mario Negri Institute for Pharmacological Research","has_results":false},{"nct_id":"NCT03493802","title":"Assessment of Longitudinal Changes in Endothelial Function and Oxidative Stress in Normotensive Patients With ADPKD","phase":"","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06496542","title":"Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":16,"lead_sponsor_name":"University of Colorado, Denver","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}